Thomas O Daniel

Thomas O Daniel has an estimated net worth of $28.2 Million. This is based on reported shares across multiple companies, which include Gossamer Bio, Inc., Magenta Therapeutics, Inc., ZAFGEN, INC., Epizyme, Inc., Juno Therapeutics, Inc., and CELGENE CORP /DE/.

2015 was Thomas O Daniel's most active year for acquiring shares with 22 total transactions. Thomas O Daniel's most active month to acquire stocks was the month of May. 2015 was Thomas O Daniel's most active year for disposing of shares, totalling 21 transactions. Thomas O Daniel's most active month to dispose stocks was the month of July. 2013 saw Thomas O Daniel paying a total of $4,676,423.51 for 150,524 shares, this is the most they've acquired in one year. In 2014 Thomas O Daniel cashed out on 190,852 shares for a total of $12,438,866.19, their largest year based on trade value.